Miracle Cure a Long Shot for Perrigo

Investors shouldn’t expect the relief rally for over-the-counter and generic-drugs maker Perrigo to last for long.

from WSJ.com: Markets http://ift.tt/2rF8O4u
via https://ifttt.com/ IFTTT